The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The endogenous cannabinoid system controls extinction of aversive memories
Abstract
Acquisition and storage of aversive memories is one of the basic principles of central nervous systems throughout the animal kingdom. In the absence of reinforcement, the resulting behavioural response will gradually diminish to be finally extinct. Despite the importance of extinction, its cellular mechanisms are largely unknown. The cannabinoid receptor 1 (CB1) and endocannabinoids are present in memory-related brain areas and modulate memory. Here we show that the endogenous cannabinoid system has a central function in extinction of aversive memories. CB1-deficient mice showed strongly impaired short-term and long-term extinction in auditory fear-conditioning tests, with unaffected memory acquisition and consolidation. Treatment of wild-type mice with the CB1 antagonist SR141716A mimicked the phenotype of CB1-deficient mice, revealing that CB1 is required at the moment of memory extinction. Consistently, tone presentation during extinction trials resulted in elevated levels of endocannabinoids in the basolateral amygdala complex, a region known to control extinction of aversive memories. In the basolateral amygdala, endocannabinoids and CB1 were crucially involved in long-term depression of GABA (gamma-aminobutyric acid)-mediated inhibitory currents. We propose that endocannabinoids facilitate extinction of aversive memories through their selective inhibitory effects on local inhibitory networks in the amygdala.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Following their binding to central nervous system receptors (e.g.CB1 receptors), endocannabinoids have been shown, e.g., to reduce anxiety (Marsicano et al., 2002;Lutz et al., 2015) and increase food intake (Di Marzo et al., 2001).”
From Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (2016) · cites this paper as Marsicano et al., 2002
In the citing paper
“Moreover, there is an emerging body of evidence demonstrating an important role for CB1 receptor-mediated endocannabinoid signaling in the extinction of aversive memories8.”
From Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study (2013) · cites this paper as [8]
In the citing paper
“As part of this protective role under aversive conditions, elevated EC signaling during stress has been shown to dampen the development of anxiety [12] and to regulate the encoding [13], retrieval [14] and extinction [15] of traumatic memories.”
From Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder (2013) · cites this paper as [15]
In the citing paper
“Additionally, inhibition of FAAH facilitates long-term fear extinction and rescues deficient fear extinction in rodent models by enhancing AEA–CB1 (cannabinoid type 1) receptor signaling and synaptic plasticity in the BLA.”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“Marsicano and colleagues reported elevated AEA and 2-AG BLA levels after extinction training in mice [86]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“One notable finding is that a CB1R-dependent form of synaptic plasticity in BLA [51,86], long-term depression of inhibitory GABAergic transmission (LTDi), is enhanced by FAAH KO [51] and by the FAAH inhibitor AM3506 at doses that promote extinction [50].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“and produced impairments in extinction learning (but not fear conditioning) by CB1R KO or systemic antagonist (SR141716A) administration [28,86]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“This suggests a scheme in which AEA released during extinction relieves a tonic inhibitory brake on BLA output neurons [50,51,86] necessary for the encoding of extinction memories [102] (Figure 2).”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“The cannabinoid system is part of the complex circuitry that regulates anxiety and stress and is a crucial mediator of emotional learning (Marsicano et al, 2002;Viveros et al, 2005;Patel et al, 2005Patel et al, , 2005a; Laviolette and Grace, 2006;Varvel et al, 2007;Ganon-Elazar and Akirav, 2009;Lutz, 2009;Hill et al, 2009;Abush and Akirav, 2010;Akirav, 2011).”
From Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (2012) · cites this paper as Marsicano et al, 2002
Citations
Cites
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Genetic enhancement of learning and memory in mice
Tang, Y., Shimizu, E., Dubé, G., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999) · Nature · doi:10.1038/43432 · Cited by 1,878
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
The role of ventromedial prefrontal cortex in the recovery of extinguished fear
Quirk, G. J., Russo, G. K., Barron, J. L., & Lebron, K. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06225.2000 · Cited by 957 · cited 1×
“; however, there is increasing evidence that some cellular pathways are specifically involved in extinction, but not in acquisition or consolidation of fear memorie”
BackgroundMarsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937
Self-citationExtinction of emotional learning: contribution of medial prefrontal cortex
Morgan, M. A., Romanski, L. M., & LeDoux, J. E. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90241-c · Cited by 897 · cited 1×
“To confirm this assumption, we measured in C57BL/6J mice levels of the two major endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), in brain punches of the medial prefrontal cortex (mPFC) and the basolateral amygdala complex (BLAC), both of which are thought to have central roles in extinction of av…”
BackgroundOhno‐Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 874
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Flagged first, then by citations
Research works printed but not linked: 1
- Franklin, K. B. J. & Paxinos, G. The Mouse Brain (Academic, San Diego, 1997)
Cited by
Sorted by citations
Items 601–700 of 1,005
Effects of General Anesthesia on Anandamide Blood Levels in Humans
Schelling, G., Hauer, D., Azad, S. C., Schmoelz, M., Choukèr, A., Schmidt, M., Hornuß, C., Rippberger, M., Briegel, J., Thiel, M., et al. (2006) · Anesthesiology · doi:10.1097/00000542-200602000-00012 · Cited by 64
Self-citationTargeting the endocannabinoid system to treat anxiety-related disorders
Korem, N., Zer‐Aviv, T. M., Ganon-Elazar, E., Abush, H., & Akirav, I. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0058 · Cited by 69
Cannabinoid Modulation of the Stressed Hippocampus
Scarante, F. F., Vila-Verde, C., Lopes, V. D., Ferreira‐Junior, N. C., Guimarães, F. S., & Campos, A. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00411 · Cited by 66
Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder
Crombie, K. M., Brellenthin, A. G., Hillard, C. J., & Koltyn, K. F. (2018) · Journal of Traumatic Stress · doi:10.1002/jts.22253 · Cited by 68
Roles for the endocannabinoid system in ethanol-motivated behavior
Henderson, A. N., Guindon, J., & Morgan, D. J. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.011 · Cited by 63
López‐Cardona, A. P., Pérez‐Cerezales, S., Fernández‐González, R., Laguna‐Barraza, R., Pericuesta, E., Agirregoitia, N., Gutiérrez‐Adán, A., & Agirregoitia, E. (2017) · The FASEB Journal · doi:10.1096/fj.201601382rr · Cited by 63
Li, L., Bender, K. J., Drew, P. J., Jadhav, S. P., Sylwestrak, E., & Feldman, D. E. (2009) · Neuron · doi:10.1016/j.neuron.2009.10.005 · Cited by 63
Maćkowiak, M., Chocyk, A., Dudys, D., & Wędzony, K. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.037 · Cited by 65
Aguirre-Rueda, D., Guerra‐Ojeda, S., Aldasoro, M., Iradi, A., Obrador, E., Mauricio, M. D., Vila, J. M., Marchio, P., & Vallés, S. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122843 · Cited by 67
The accurate measurement of fear memory in Pavlovian conditioning: Resolving the baseline issue
Jacobs, N. S., Cushman, J. D., & Fanselow, M. S. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.04.029 · Cited by 61
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthoodPreprint
Alteba, S., Korem, N., & Akirav, I. (2016) · Learning & Memory · doi:10.1101/lm.041608.116 · Cited by 63
Ramikie, T. S., & Patel, S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.037 · Cited by 62
Analysis of the Endocannabinoid System by Using CB1 Cannabinoid Receptor Knockout Mice
Valverde, O., Karsak, M., & Zimmer, A. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_4 · Cited by 61
Espejo‐Porras, F., Piscitelli, F., Verde, R., Ramos, J. A., Marzo, V. D., de Lago, E., & Fernández‐Ruíz, J. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9602-4 · Cited by 62
Marco, E. M., Adriani, W., Canese, R., Podo, F., Viveros, M., & Laviola, G. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.006 · Cited by 62
Acute Effects of Marijuana Smoking on Negative and Positive Affect
Metrik, J., Kahler, C. W., McGeary, J. E., Monti, P. M., & Rohsenow, D. J. (2011) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.25.1.31 · Cited by 67
The Many Forms and Functions of Long Term Plasticity at GABAergic Synapses
Maffei, A. (2011) · Neural Plasticity · doi:10.1155/2011/254724 · Cited by 67
Jiao, X., Pang, K. C. H., Beck, K. D., Minor, T. R., & Servatius, R. J. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.02.029 · Cited by 68
Micale, V., Stepan, J., Jurik, A., Pamplona, F. A., Marsch, R., Drago, F., Eder, M., & Wotjak, C. T. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.02.002 · Cited by 62
Self-citationHippocampal CB1 Receptors Control Incidental Associations
Busquets-García, A., da Cruz, J. F. O., Terral, G., Zottola, A. C. P., Gómez, E. S., Contini, A., Martin, H., Redon, B., Varilh, M., Ioannidou, C., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.08.014 · Cited by 68
Self-citationDopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSD
Ney, L. J., Akhurst, J., Bruno, R., Laing, P. A. F., Matthews, A. J., & Felmingham, K. L. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110118 · Cited by 62
The effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice
Mikics, É., Dombi, T., Barsvári, B., Varga, B., Ledent, C., Freund, T., & Haller, J. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200605000-00003 · Cited by 61
Cain, C. K., Godsil, B. P., Jami, S. A., & Barad, M. (2005) · Learning & Memory · doi:10.1101/lm.88805 · Cited by 62
Bashashati, M., Storr, M., Nikas, S. P., Wood, J., Godlewski, G., Liu, J., Ho, W. ‐. V., Keenan, C. M., Zhang, H., Alapafuja, S. O., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01644.x · Cited by 61
Self-citationThe MAP(K) of fear: From memory consolidation to memory extinction
Cestari, V., Rossi‐Arnaud, C., Saraulli, D., & Costanzi, M. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.09.007 · Cited by 62
2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation
Petrosino, S., Campolo, M., Impellizzeri, D., Paterniti, I., Allarà, M., Gugliandolo, E., D’Amico, R., Siracusa, R., Cordaro, M., Esposito, E., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00308 · Cited by 61
Stress response recruits the hippocampal endocannabinoid system for the modulation of fear memoryPreprint
Alvares, L. D. O., Engelke, D. S., Diehl, F., Scheffer-Teixeira, R., Haubrich, J., Cassini, L. F., Molina, V. A., & Quillfeldt, J. A. (2010) · Learning & Memory · doi:10.1101/lm.1721010 · Cited by 61
Cedernaes, J., Fanelli, F., Fazzini, A., Pagotto, U., Broman, J.-E., Vogel, H., Dickson, S. L., Schiöth, H. B., & Benedict, C. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.09.014 · Cited by 59
Morena, M., Aukema, R. J., Leitl, K. D., Rashid, A. J., Vecchiarelli, H. A., Josselyn, S. A., & Hill, M. N. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2251-18.2018 · Cited by 68
Functional heterogeneity of POMC neurons relies on mTORC1 signaling
Saucisse, N., Mazier, W., Simon, V., Binder, E., Catania, C., Bellocchio, L., Romanov, R. A., Leon, S., Matias, I., Zizzari, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109800 · Cited by 63
Self-citationLeweke, F. M., Gerth, C. W., & tter, J. K. (2004) · CNS Drugs · doi:10.2165/00023210-200418130-00005 · Cited by 60
Huang, Y. Y., Yasuda, H., Sarihi, A., & Tsumoto, T. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0899-08.2008 · Cited by 62
Cluny, N. L., Keenan, C. M., Duncan, M., Fox, A., Lutz, B., & Sharkey, K. A. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.169946 · Cited by 60
Self-citationBayatti, N., Hermann, H., Lutz, B., & Behl, C. (2005) · Endocrinology · doi:10.1210/en.2004-1154 · Cited by 60
Self-citationWiedenmayer, C. P. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.09.005 · Cited by 60
Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats
Robinson, L., McKillop‐Smith, S., Ross, N. L., Pertwee, R. G., Hampson, R. E., Platt, B., & Riedel, G. (2007) · Psychopharmacology · doi:10.1007/s00213-007-1012-8 · Cited by 60
Implicit operant learning of pain sensitization
Hölzl, R., Kleinböhl, D., & Huse, E. (2005) · Pain · doi:10.1016/j.pain.2005.01.026 · Cited by 61
A cortico-amygdala neural substrate for endocannabinoid modulation of fear extinction
Gunduz‐Cinar, O., Castillo, L. I., Xia, M. Y., Leer, E. V., Brockway, E. T., Pollack, G. A., Yasmin, F., Bukalo, O., Limoges, A., Oreizi-Esfahani, S., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.06.023 · Cited by 64
Cannabidiol and brain function: current knowledge and future perspectives
Schouten, M., Dalle, S., Mantini, D., & Koppo, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1328885 · Cited by 64
Storr, M., Bashashati, M., Hirota, C. L., Vemuri, K. V., Keenan, C. M., Duncan, M., Lutz, B., Mackie, K., Makriyannis, A., MacNaughton, W. K., et al. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01478.x · Cited by 59
Self-citationSchwendt, M., Shallcross, J., Hadad, N. A., Namba, M. D., Hiller, H., Wu, L., Krause, E. G., & Knackstedt, L. A. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0265-9 · Cited by 60
Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder
Muhie, S., Gautam, A., Meyerhoff, J., Chakraborty, N., Hammamieh, R., & Jett, M. (2015) · Molecular Brain · doi:10.1186/s13041-015-0104-3 · Cited by 58
Crombie, K. M., Sartin‐Tarm, A., Sellnow, K. A., Ahrenholtz, R., Lee, S., Matalamaki, M., Almassi, N. E., Hillard, C. J., Koltyn, K. F., Adams, T. G., et al. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105355 · Cited by 59
Straiker, A. J., Wager‐Miller, J., Hu, S. S., Blankman, J., Cravatt, B., & Mackie, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01486.x · Cited by 58
Melis, M., Sagheddu, C., Felice, M. D., Casti, A., Madeddu, C., Spiga, S., Muntoni, A. L., Mackie, K., Marsicano, G., Colombo, G., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1844-14.2014 · Cited by 58
Self-citationEndocannabinoids and Their Implications for Epilepsy
Alger, B. E. (2004) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7597.2004.04501.x · Cited by 58
Korem, N., & Akirav, I. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.132 · Cited by 61
The Endocannabinoid 2-Arachidonoyl-Glycerol Controls Odor Sensitivity in Larvae of Xenopus laevis
Breunig, E., Manzini, I., Piscitelli, F., Gutermann, B., Marzo, V. D., Schild, D., & Czesnik, D. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4030-09.2010 · Cited by 56
Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies
Khoury, M. E., Gorgievski, V., Moutsimilli, L., Bruno Giros, A., & Tzavara, E. T. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.005 · Cited by 58
Cognitive enhancers for facilitating drug cue extinction: Insights from animal models
Dhonnchadha, B. Á. N., & Kantak, K. M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.018 · Cited by 57
Lisboa, S. F. D. S., Gomes, F. V., Silva, A. L., Uliana, D. L., Camargo, L. H. A., Guimarães, F. S., Cunha, F. Q., Joca, S. R. L., & Resstel, L. B. M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv005 · Cited by 61
Sex differences in hippocampal response to endocannabinoids after exposure to severe stress
Zer‐Aviv, T. M., & Akirav, I. (2016) · Hippocampus · doi:10.1002/hipo.22577 · Cited by 61
Does the amygdala modulate adaptation to repeated stress?
Carter, R. N., Pinnock, S. B., & Herbert, J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.01.018 · Cited by 58
Role of cortical cannabinoid CB1 receptor in conditioned taste aversion memory
Kobilo, T., Hazvi, S., & Dudai, Y. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05561.x · Cited by 60
Battaglia, S., Fazio, C. D., Vicario, C. M., & Avenanti, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065926 · Cited by 56
Haj‐Dahmane, S., & Shen, R. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.190066 · Cited by 57
Puente, N., Elezgarai, I., Lafourcade, M., Reguero, L., Marsicano, G., Georges, F. E., Manzoni, O. J., & Grandes, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008869 · Cited by 63
Self-citationDynorphins Regulate Fear Memory: from Mice to Men
Bilkei‐Gorzó, A., Erk, S., Schurmann, B., Mauer, D., Michel, K., Boecker, H., Scheef, L., Walter, H., & Zimmer, A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1034-12.2012 · Cited by 59
Campos, A. C., Ferreira, F. R., Silva, W. A., & Guimarães, F. S. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.11.016 · Cited by 57
New Insights into the Pathophysiology and Treatment of Fibromyalgia
Schmidt‐Wilcke, T., & Diers, M. (2017) · Biomedicines · doi:10.3390/biomedicines5020022 · Cited by 57
Shallcross, J., Hámor, P. U., Bechard, A. R., Romano, M., Knackstedt, L. A., & Schwendt, M. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00091 · Cited by 61
The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons
Lau, T., & Schloss, P. D. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.09.022 · Cited by 57
Antel, J., Gregory, P. C., & Nordheim, U. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm058238r · Cited by 57
Rabinak, C. A., Blanchette, A., Zabik, N. L., Peters, C., Marusak, H. A., Iadipaolo, A. S., & Elrahal, F. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05499-8 · Cited by 57
Weber, J., Schley, M. T., Casutt, M., Gerber, H., Schuepfer, G., Rukwied, R., Schleinzer, W., Ueberall, M. A., & Konrad, C. J. (2009) · Anesthesiology Research and Practice · doi:10.1155/2009/827290 · Cited by 56
Cluny, N. L., Keenan, C. M., Lutz, B., Piomelli, D., & Sharkey, K. A. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01248.x · Cited by 56
Self-citationMolecular Biology of Cannabinoid Receptors
Abood, M. E. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_3 · Cited by 56
Mechanisms of endocannabinoid transport in the brain
Kaczocha, M., & Haj‐Dahmane, S. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15469 · Cited by 60
Removing Pathogenic Memories: A Neurobiology of Psychotherapy
Centonze, D., Siracusano, A., Calabresi, P., & Bernardi, G. (2005) · Molecular Neurobiology · doi:10.1385/mn:32:2:123 · Cited by 61
Bisogno, T., & Marzo, V. D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.002 · Cited by 59
Self-citationGuidali, C., Viganò, D., Petrosino, S., Zamberletti, E., Realini, N., Binelli, G., Rubino, T., Marzo, V. D., & Parolaro, D. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000209 · Cited by 56
Pharmacological enhancement of fear reduction: preclinical models
Graham, B. M., Langton, J. M., & Richardson, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01175.x · Cited by 57
An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters
Moise, A. M., Eisenstein, S. A., Astarita, G., Piomelli, D., & Hohmann, A. G. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1209-5 · Cited by 55
Nasehi, M., Sahebgharani, M., Haeri-Rohani, A., & Zarrindast, M. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.05.005 · Cited by 56
Martín‐García, E., Bourgoin, L., Cathala, A., Kasanetz, F., Mondésir, M., Gutiérrez‐Rodrίguez, A., Reguero, L., Fiancette, J.-F., Grandes, P., Spampinato, U., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.351 · Cited by 60
Self-citationThe Endocannabinoid System and Anxiety
Lisboa, S. F. D. S., Gomes, F. V., Terzian, A. L. B., de Aguiar, D. C., Moreira, F. A., Resstel, L. B. M., & Guimarães, F. S. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.09.006 · Cited by 56
Function and mechanisms of memory destabilization and reconsolidation after retrieval
Kida, S. (2020) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.96.008 · Cited by 57
Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists
Hill, M. N., Froese, L. M., Morrish, A. C., Sun, J. C., & Floresco, S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0421-4 · Cited by 57
Lisboa, S. F., Vila-Verde, C., Rosa, J., Uliana, D. L., Stern, C. A. J., Bertoglio, L. J., Resstel, L. B., & Guimaraes, F. S. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5127-x · Cited by 54
Cannabis in India: ancient lore and modern medicine
Russo, E. B. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_1 · Cited by 54
Role of the Hippocampus and Amygdala in the Extinction of Fear- Motivated Learning
Vianna, M. R. M. R., Coitinho, A. S., & Izquierdo, I. (2004) · Current Neurovascular Research · doi:10.2174/1567202043480170 · Cited by 54
Bowers, M. E., & Ressler, K. J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.225 · Cited by 54
Revisiting the flip side: Long-term depression of synaptic efficacy in the hippocampus
Pinar, C., Fontaine, C. J., Triviño-Paredes, J., Lottenberg, C. P., Gil‐Mohapel, J., & Christie, B. R. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.06.001 · Cited by 60
Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events
Davidson, C., Opacka‐Juffry, J., Arévalo‐Martín, Á., García‐Ovejero, D., Molina‐Holgado, E., & Molina‐Holgado, F. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.05.001 · Cited by 55
Rengachari, S., Bezerra, G. A., Riegler-Berket, L., Gruber, C. C., Sturm, C., Taschler, U., Boeszoermenyi, A., Dreveny, I., Zimmermann, R., Gruber, K. F., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.04.006 · Cited by 54
Stumm, C., Hiebel, C., Hanstein, R., Purrio, M., Nagel, H., Conrad, A., Lutz, B., Behl, C., & Clement, A. B. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.027 · Cited by 54
Self-citationEndocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats
Lim, J., Igarashi, M., Jung, K., Butini, S., Campiani, G., & Piomelli, D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.284 · Cited by 53
Xu, Z., Lv, X., Dai, Q., Ge, Y., & Xu, J. (2016) · Molecular Brain · doi:10.1186/s13041-016-0257-8 · Cited by 53
Design of a Neurally Plausible Model of Fear Learning
Krasne, F. B., Fanselow, M. S., & Zelikowsky, M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00041 · Cited by 51
Hasanein, P., & Far, M. T. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.02.007 · Cited by 52
Cannabinoid receptor type 1 expression during postnatal development of the rat retina
Zabouri, N., Bouchard, J., & Casanova, C. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22534 · Cited by 52
Descalzi, F., Ulivi, V., Cancedda, R., Piscitelli, F., Luongo, L., Guida, F., Gatta, L., Maione, S., & Marzo, V. D. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0557 · Cited by 52
Effects of endocannabinoid and endovanilloid systems on aversive memory extinction
Laricchiuta, D., Centonze, D., & Petrosini, L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.010 · Cited by 54
Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples
Vogeser, M., & Schelling, G. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.197 · Cited by 51
Leishman, E., Cornett, B., Spork, K., Straiker, A. J., Mackie, K., & Bradshaw, H. B. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.020 · Cited by 52
Stern, C. A. J., de Carvalho, C. R., Bertoglio, L. J., & Takahashi, R. N. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.07.018 · Cited by 53
Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings
Kesner, A. J., & Lovinger, D. M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15369 · Cited by 58
Dual Ca2+ modulation of glycinergic synaptic currents in rodent hypoglossal motoneurones
Mukhtarov, M. R., Ragozzino, D., & Bregestovski, P. D. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.094862 · Cited by 52
Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia
Berger, A. A., Keefe, J., Winnick, A. A., Gilbert, E., Eskander, J. P., Yazdi, C., Kaye, A. D., Viswanath, O., & Urits, I. (2020) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2020.08.010 · Cited by 57
Thiemann, G., VANDERSTELT, M., Petrosino, S., Molleman, A., Marzo, V. D., & Hasenöhrl, R. U. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.09.022 · Cited by 51
Metadata
- Authors
- Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., Di Marzo, V., & Lutz, B.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- LMU Klinikum (DE)
- Istituto di Chimica Biomolecolare (IT)
- Helmholtz Munich (DE)
- Corresponding author
- Lutz, Beat
- Venue
- Nature
- Published
- 2002-08
- Volume
- 418
- Issue
- 6897
- Pages
- 530-534
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1982291289
- Cited by
- 1,728
- References
- 30
- Citations by year
- 2026: 22 · 2025: 39 · 2024: 41 · 2023: 48 · 2022: 60 · 2021: 61 · 2020: 60 · 2019: 70 · 2018: 64 · 2017: 77 · 2016: 75 · 2015: 87 · 2014: 90 · 2013: 87 · 2012: 85
- FWCI
- 42.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- endocannabinoid system, CB1 receptor, CB1 knockout mice, fear extinction, auditory fear conditioning, basolateral amygdala, long-term depression, GABAergic inhibition, SR141716A, memory consolidation, inhibitory neural networks
- MeSH terms
- Rimonabant, Acoustic Stimulation, Amygdala, Animals, Cannabinoids, Conditioning, Classical, Electrophysiology, Extinction, Psychological, Fear, gamma-Aminobutyric Acid, Male, Memory, Mice, Inbred C57BL, Neuronal Plasticity, Neurons, Piperidines, Pyrazoles, Receptors, Drug, Synapses, Gene Deletion, Mice, Knockout, Receptors, Cannabinoid, Mice, Cannabinoid Receptor Modulators, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
